Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

1. Efficacy, safety, and public attitude toward COVID-19 vaccines: A systematic review.Annals of African medicine
   Pooled it
2. Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.iScience · 2025
   Article
3. Pathophysiological, immunological, and inflammatory features of long COVID.Frontiers in immunology · 2024
   Review
4. Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.Frontiers in immunology · 2024
   Article
5. Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVacVaccines · 2023
   Article
6. Statistical explanation of the protective effect of four COVID-19 vaccine doses in the general population.Frontiers in public health · 2023
   Article
7. A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.mBio · 2022
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

31 authors at 7 institutions in 1 country.

Funding

Abstract

Indexed as